| Literature DB >> 29912936 |
Kazumasa Sekihara1,2, Kaori Saitoh1, Haeun Yang1,2, Haruki Kawashima3, Saiko Kazuno4, Mika Kikkawa4, Hajime Arai4, Takashi Miida1, Nobuhiro Hayashi3, Keisuke Sasai5, Yoko Tabe1,6.
Abstract
The effects of the high-dose ionizing radiation used in radiotherapy have been thoroughly demonstrated in vitro and in vivo. However, the effects of low-dose ionizing radiation (LDIR) such as computed tomography-guided biopsies and X-ray fluoroscopy on skin cells remain controversial. This study investigated the molecular effects of LDIR on the human primary keratinocytes (HPKs) and U937 cells, monocytes-like cell lines. These cells were exposed to 0.1 Gray (Gy) X-ray as LDIR. The modulation of transcription was assessed using a cDNA array, and the protein expression after LDIR exposure was investigated using isobaric tags for relative and absolute quantification (iTRAQ) proteomic analysis at 24 hours. These effects were confirmed by immunoblotting analysis. The direct effects of LDIR on the U937 cells and HPKs and the bystander effects of irradiated HPKs on U937 cells were also investigated. LDIR downregulated c-Myc in both U937 cells and HPKs, and upregulated the p21WAF1/CIP1 protein expression in U937 cells along with the activation of TGFβ and protein phosphatase 2A (PP2A). In HPKs, LDIR downregulated the mTOR signaling with repression of S6 and 4EBP1 activation. Similar changes were observed as bystander effects of LDIR. Our findings suggest that LDIR inhibits protein synthesis and induces the cytokines activation associated with inflammation via direct and bystander effects, which might recapitulate the effects of LDIR in inflammated skin structures.Entities:
Mesh:
Year: 2018 PMID: 29912936 PMCID: PMC6005503 DOI: 10.1371/journal.pone.0199117
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Upstream factors involved in alterations of gene transcription caused by LDR in U937 cells (at 24 hours).
| Upstream Regulator | Activation z-score | P-value |
|---|---|---|
| U937-IR | ||
| Activated | ||
| TNF | 2.18 | 3.11E-01 |
| CSF2 | 2.13 | 2.31E-01 |
| IFNG | 2.07 | 2.14E-01 |
| E2F3 | 1.98 | 2.29E-02 |
| Akt | 1.97 | 8.86E-02 |
| IL5 | 1.96 | 1.49E-01 |
| IL1B | 1.96 | 1.00E00 |
| IL1A | 1.95 | 7.62E-02 |
| Inhibited | ||
| N.A. | ||
| U937-(IR)-BS | ||
| Activated | ||
| MGEA5 | 2.84 | 5.13E-01 |
| FSH | 2.08 | 1.00E00 |
| SFTPA1 | 2.00 | 3.51E-01 |
| Nr1h | 1.98 | 1.00E00 |
| SYVN1 | 1.98 | 3.32E-03 |
| MMP3 | 1.90 | 1.01E-02 |
| FLT1 | 1.89 | 2.62E-02 |
| AKT1 | 1.83 | 3.59E-01 |
| TGFB1 | 1.82 | 1.00E00 |
| KLF4 | 1.81 | 1.00E00 |
| Inhibited | ||
| REL | -2.58 | 1.39E-01 |
| SMARCA4 | -2.56 | 4.78E-01 |
| IRF7 | -2.42 | 6.75E-02 |
| HIF1A | -2.41 | 5.34E-01 |
| TNF | -2.23 | 1.00E00 |
| TICAM1 | -2.22 | 1.00E00 |
| TNFRSF1A | -2.22 | 1.00E00 |
| Ifn | -2.19 | 5.22E-01 |
| NR1H4 | -2.18 | 1.00E00 |
| S100A9 | -2.16 | 3.22E-01 |
| PKD1 | -2.00 | 1.00E00 |
| HNF4A | -1.99 | 1.01E-03 |
| IKBKG | -1.98 | 5.52E-01 |
| CXCL12 | -1.94 | 1.31E-01 |
| CSF2 | -1.93 | 1.00E-01 |
| S100A8 | -1.92 | 3.89E-01 |
| IRF5 | -1.89 | 2.13E-02 |
| CST5 | -1.89 | 3.34E-02 |
| CXCR4 | -1.88 | 7.55E-02 |
| FOXO1 | -1.82 | 2.11E-01 |
| IFNG | -1.82 | 1.00E00 |
Data were analyzed using Ingenuity Pathway Analysis (IPA) based on genes for which transcription was consistently altered after treatment in U937 cells.
Upstream factors involved in the protein expression responses to LDIR in U937 cells and HPKs (at 24 hours).
| Upstream Regulator | Activation z-score | p-value of overlap | Target molecules in dataset |
|---|---|---|---|
| U937-IR | |||
| Activated | |||
| OSM | 1.63 | 4.15E-03 | ARHGEF2,GART,LRRFIP1,OGDH,PCNA,PGK1 |
| Inhibited | |||
| PRL | -2.39 | 1.32E-04 | CTSD,MSN,P4HB,PCNA,RPSA,YWHAG |
| EGFR | -1.67 | 1.42E-05 | CCT5,HNRNPA2B1,HSPE1,IGBP1,PCNA,PPIA,PSMB1,TUBA4A |
| U937-(IR)-BS | |||
| Activated | |||
| TP53 | 1.84 | 6.61E-03 | ACTN1,ARPC1B,EZR,HSPB1,PCNA,SFPQ,SOD1 |
| Inhibited | |||
| HIF1A | -2.21 | 2.42E-05 | ALDOA,EIF5A,HSPA5,HSPB1,PGK1,PPIA |
| HPK-IR | |||
| Activated | |||
| FGF2 | 2.37 | 5.67E-05 | ALB, FLNA, ITGB1, PRKDC, THBS1, XRCC5, XRCC6 |
| IL4 | 2.24 | 5.94E-03 | ANXA2, IDE, ITGB1, NCL, PRKDC, XRCC5, XRCC6 |
| INSR | 2.21 | 8.61E-05 | ACTN4, ATP5B, FH, HADHA, HSPD1, MDH2, RAB7A |
| IFNG | 2.01 | 6.05E-02 | HSPD1, IDE, ITGB1, KRT14, LAMC2, PSME3, THBS1 |
| ESRRA | 1.95 | 1.34E-03 | ATP5B, HADHA, HK1, LDHA |
| TNF | 1.90 | 1.90E-02 | ALB,HSPD1,IDE,ITGB1,LAD1,LAMC2,LDHA,RPS3,THBS1,TPP2 |
| TP63 | 1.68 | 3.83E-03 | CAD,ITGB1,KRT14,KRT6A,THBS1 |
| PRL | 1.62 | 9.94E-05 | ACTR3,ANXA2,HSPD1,IDE,KRT14,KRT5 |
| Inhibited | |||
| CST5 | -2.00 | 6.95E-03 | AHNAK,ANXA2,HNRNPU,NCL |
| CD3 | -1.67 | 1.21E-07 | ACTN4,ACTR3,HNRNPA1,KRT14,MDH2,NCL,NPM1,SF1,SSB,THBS1,XRCC6,YARS |
| CD28 | -1.63 | 3.52E-04 | ACTR3,HNRNPA1,NCL,SSB,THBS1,XRCC6 |
Data were analyzed by Ingenuity Pathway Analysis (IPA) based on the proteins whose expression was consistently altered after the indicated treatment in U937 cells and HPKs (S2 Table).
Fig 1Molecular pathways affected by LDIR in U937 cells and HPKs.
After direct LDIR for 24 hours or in the bystander condition, the cells were subjected to lysis and immunoblot analyses. The results are representative of three independent experiments, and the intensity of each immunoblot signal compared with that of α-tubulin was quantified using ImageJ software; the quantity is shown directly under each blot.
Fig 2LDIR inhibits cell growth and protein synthesis and induces bystander effects.
Cell signaling pathways affected by LDIR. LDIR downregulates c-Myc and upregulates p21 WAF1/CIP1 via stimulation of TGFβ and PP2A. PP2A also inhibits mTOR signaling with repression of S6K activation and 4EBP1 phosphorylation that resulted in decrease in protein synthesis. Furthermore, LDIR induces bystander effects through p38 MAPK activation. Directly-irradiated cells release cytokine signals that affect non-irradiated (bystander) cells.